Article Details
Retrieved on: 2022-08-19 12:43:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Truist Securities analyst Joon Lee said the approval “represents a turning point for the company” and that the drug could be a commercial success ...
Article found on: www.thebharatexpressnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here